Luminor Medical Technologies Inc. (‘the company’) announced that it has completed the acquisition of RISE Research Inc. The company also announced the appointment of Chris Dollard to the Board of Directors. Mr. Dollard, co-founder of RISE Research, will also immediately take on the role of Chief Operating Officer of the company. The company also nominates Constance Finley, the CEO of Constance Therapeutics, to the Board. Ms. Finley plans to officially join the Board upon ratification at the Annual General Meeting. To accommodate these appointments, Mr. Christian Sauvageau has resigned from his former board and officer positions.